CVI Holdings’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

CVI Holdings’s Portfolio SBFMW Stock Details SBFMW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-74,632	Closed	-$74K	–	945
2022 Q1	$74K	Buy	+74,632	New	+$52.1K	﹤0.01%	566

Other funds holding SBFMW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

CVI Holdings's SBFMW Position: Q2 2022 in Review

CVI Holdings sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q2 2022, closing a stake of 74,632 shares — an estimated $74K sold.

CVI Holdings first reported a position in SBFMW in Q1 2022 and held it in 1 quarter. The position peaked at $74K in Q1 2022. 4 funds tracked by Wall St. Rank hold SBFMW as of Q2 2022.

CVI Holdings reported no remaining Sunshine Biopharma Inc Warrant position as of Q2 2022 after selling out during the quarter.
CVI Holdings sold 74,632 Sunshine Biopharma Inc Warrant shares in Q2 2022, an estimated $74K.
CVI Holdings first reported a position in Sunshine Biopharma Inc Warrant in Q1 2022 and held it in 1 quarter.
CVI Holdings's Sunshine Biopharma Inc Warrant position peaked at $74K in Q1 2022.
4 funds tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q2 2022.

Based on CVI Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.